A fourth of patients with metastatic breast cancer had asymptomatic brain metastases detected within 6 months after enrolling in a study of MRI-based surveillance. Baseline brain MRI results showed ...
A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to rethink current screening ...
Brain metastases are a common problem in patients with EGFR-mutated non-small cell lung cancer (NSCLC), occurring in about one-fifth to one-quarter of patients. Many brain metastases will be ...
Hosted on MSN
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
Brain metastases often occur as a result of advanced cancer, and despite medical innovations, are still associated with a poor prognosis. Now, an international expert committee led by the Medical ...
Asymptomatic brain metastasis in stage 4 breast cancer requires reevaluation of screening guidelines
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study, published in ...
The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
RAD101 targets fatty acid synthase, overexpressed in many solid tumors, to improve brain metastases imaging. Fast track designation by the FDA accelerates development for treatments addressing unmet ...
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to interim results. To date, 11 of the 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results